Literature DB >> 8075582

New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens.

P Engel1, T F Tedder.   

Abstract

This review summaries the expression and the molecular and biochemical characteristics of eight new Clusters of Differentiation (CD79-CD86) established by the B cell Section during the Fifth International Workshop on Human Leukocyte Differentiation Antigens. CD79 monoclonal antibodies (mAb) identify the mbl (CD79 alpha) and B29 (CD79 beta) components of the surface immunoglobulin (Ig) receptor complex. CD80 (B7/BB-1) is a costimulatory molecule that serves as the ligand for two molecules expressed on T lymphocytes, CD28 and CTLA-4. CD81 (TAPA-1) and CD82 (R2) are new members of the tetra-spans family of transmembrane proteins, which include CD9, CD37, CD53 and CD63. These proteins are postulated to be involved in signal transduction. CD83 (HB15) is a marker for human interdigitating reticulum cells, circulating dendritic cells and Langerhans cells. CDw84 and CD85 are new B cell-associated molecules that are also expressed by monocytes. CD86 is a new B cell activation antigen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075582     DOI: 10.3109/10428199409052677

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Genetic dissection of the Gpnmb network in the eye.

Authors:  Hong Lu; Xusheng Wang; Matthew Pullen; Huaijin Guan; Hui Chen; Shwetapadma Sahu; Bing Zhang; Hao Chen; Robert W Williams; Eldon E Geisert; Lu Lu; Monica M Jablonski
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-13       Impact factor: 4.799

2.  CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses.

Authors:  H T Maecker; M S Do; S Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Finding the right RNA: identification of cellular mRNA substrates for RNA-binding proteins.

Authors:  P Trifillis; N Day; M Kiledjian
Journal:  RNA       Date:  1999-08       Impact factor: 4.942

4.  Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.

Authors:  Usman A Ashfaq; Muhammad Qasim; Muhammad Z Yousaf; Muhammad Tariq Awan; Shah Jahan
Journal:  J Transl Med       Date:  2011-11-10       Impact factor: 5.531

5.  Normal lymphocyte development but delayed humoral immune response in CD81-null mice.

Authors:  H T Maecker; S Levy
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

6.  Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells.

Authors:  Wei Lin; Konrad Buscher; Beibei Wang; Zhichao Fan; Nannan Song; Peng Li; Yingying Yue; Bingqing Li; Cuiling Li; Hongsheng Bi
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

Review 7.  Dendritic cells: immunological sentinels with a central role in health and disease.

Authors:  L H Stockwin; D McGonagle; I G Martin; G E Blair
Journal:  Immunol Cell Biol       Date:  2000-04       Impact factor: 5.126

Review 8.  The CD83 Molecule - An Important Immune Checkpoint.

Authors:  Linda Grosche; Ilka Knippertz; Christina König; Dmytro Royzman; Andreas B Wild; Elisabeth Zinser; Heinrich Sticht; Yves A Muller; Alexander Steinkasserer; Matthias Lechmann
Journal:  Front Immunol       Date:  2020-04-17       Impact factor: 7.561

9.  Structural characterization of recombinant human CD81 produced in Pichia pastoris.

Authors:  Mohammed Jamshad; Sundaresan Rajesh; Zania Stamataki; Jane A McKeating; Timothy Dafforn; Michael Overduin; Roslyn M Bill
Journal:  Protein Expr Purif       Date:  2007-10-24       Impact factor: 1.650

10.  Tetraspanin CD82 is necessary for muscle stem cell activation and supports dystrophic muscle function.

Authors:  Arielle Hall; Tatiana Fontelonga; Alec Wright; Katlynn Bugda Gwilt; Jeffrey Widrick; Alessandra Pasut; Francesco Villa; Cynthia K Miranti; Devin Gibbs; Evan Jiang; Hui Meng; Michael W Lawlor; Emanuela Gussoni
Journal:  Skelet Muscle       Date:  2020-11-27       Impact factor: 4.912

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.